Wegovy vs Mounjaro: Which Treatment Suits Your Lifestyle?
What Is The Difference Between Wegovy And Mounjaro Availability In The UK?
The most significant difference for UK patients is current availability and supply consistency. Wegovy, manufactured by Novo Nordisk, has experienced supply constraints historically, but EverydayMeds now maintains reliable stock of all five doses (0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg) with no waiting lists required. Mounjaro (tirzepatide) from Eli Lilly has generally maintained more consistent UK supply since its launch.
Both prescription-only medicines are available through our streamlined online service, with identical ordering processes and delivery timelines. Your clinical assessment takes just 3 minutes, followed by prescriber review within 3 working days (or 24 hours with express service), then next-day temperature-controlled delivery once approved. This eliminates the uncertainty many patients face when trying to access weight management treatments through traditional healthcare pathways.
Wegovy Vs Mounjaro Pricing And Value Comparison
Understanding the cost difference between Wegovy and Mounjaro helps inform your treatment decision. Wegovy starts at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Our Getting Started bundles provide convenience, such as the Intro Duo (0.25mg & 0.5mg) for £169.99, covering your first two months.
New customers apply code FIRST40 at checkout to reach these prices, whilst returning customers use DOSE25. Both treatments require similar dose escalation schedules over 16-20 weeks, so comparing long-term costs alongside clinical suitability helps determine the most appropriate option. Our Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, ensuring uninterrupted treatment once you reach your target dose.
Clinical Evidence: What Is The Difference Between Wegovy And Mounjaro Efficacy?
Wegovy's clinical evidence comes primarily from the STEP trial programme, where patients taking semaglutide alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in STEP 1, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 5 trial demonstrated sustained clinically studied weight loss at 2 years, whilst SELECT showed a 20% reduction in major cardiovascular events.
Mounjaro's evidence stems from the SURMOUNT trials, showing different efficacy profiles due to its dual mechanism of action. However, comparing trial results directly isn't clinically meaningful, as studies involved different patient populations, endpoints, and methodologies. Both treatments are designed to support weight management when used appropriately under medical supervision.
How Wegovy Works: The Difference In Mechanism Of Action
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural fullness hormone produced in your intestines. This mechanism may help reduce appetite and promote feelings of satiety after smaller meals, potentially making it easier to maintain a reduced-calorie diet. The treatment works on brain appetite centres, which may help reduce food cravings and the psychological aspects of overeating. Mounjaro, by contrast, targets both GIP and GLP-1 receptors simultaneously, creating a dual pathway approach to appetite regulation and glucose control. Your prescriber can help determine which mechanism might be more suitable based on your individual health profile and weight management goals.
Ordering Process: What's The Difference Between Getting Wegovy And Mounjaro?
The ordering process for both treatments is identical through EverydayMeds, eliminating confusion about accessing different medications. You'll complete our 3-minute clinical assessment covering medical history, current medications, and weight management goals, which our UK-registered prescribers review within 3 working days (24 hours with express service). Once approved, both treatments ship via next-day cold-chain delivery in temperature-controlled packaging to maintain medication integrity. The assessment considers factors like BMI, weight-related health conditions, previous treatment experience, and lifestyle factors to determine the most appropriate starting dose and escalation schedule. Both require identical monitoring and follow-up protocols throughout your treatment journey.
Storage And Practical Differences Between Wegovy And Mounjaro
Storage requirements reveal a key practical difference that may influence your choice between treatments. Both require refrigeration at 2-8°C before first use, but Wegovy offers superior travel convenience with 6 weeks of room temperature storage (below 30°C) once removed from the fridge, compared to Mounjaro's 21-day limit. Both use similar injection pen technology, though Wegovy's FlexTouch pen system has been refined over several years of market availability. The dose escalation schedule differs slightly between treatments, with Wegovy following a structured 16-week progression to the 2.4mg maintenance dose, whilst Mounjaro has its own escalation protocol. Both require weekly injections at the same time each week, preferably in the thigh, upper arm, or abdomen.
UK Stock Availability: Real-Time Difference Between Wegovy And Mounjaro Access
Current UK stock levels represent perhaps the most practical difference when choosing between these treatments. EverydayMeds maintains comprehensive Wegovy inventory across all licensed doses, addressing historical supply concerns that affected patient treatment continuity. Our direct supply relationship with Novo Nordisk ensures reliable stock replenishment, whilst our pharmacy management system provides real-time availability updates. This eliminates the frustrating delays patients previously experienced when trying to collect prescriptions from local pharmacies.
Mounjaro availability has remained more consistent since its UK launch, though demand continues growing as awareness increases. Having both treatments readily available means your choice can focus on clinical suitability rather than supply constraints. Our pharmacy team monitors stock levels continuously, with automatic reordering systems ensuring we maintain adequate supplies of both treatments for new and continuing patients.
Making Your Treatment Choice: Wegovy Or Mounjaro Through EverydayMeds
Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment aligns better with your individual circumstances. Consider factors like travel requirements (Wegovy's extended room temperature stability), cost considerations across the full treatment duration, and any specific health conditions that might favour one mechanism over another. Our clinical assessment captures these nuances to guide appropriate prescribing decisions. Start with our 3-minute assessment today, using code FIRST40 for new customers or DOSE25 for returning patients, with treatments available from £79.99 including next-day delivery to anywhere in the UK. Visit https://everydaymeds.co.uk/collections/wegovy to begin your weight management journey with either treatment option available immediately.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
